[Autotransplantation in acute leukemia using totipotent cells mobilized with filgrastim].
Ruiz-Argüelles
G J
GJ
Centro de Hematología y Medicina Interna de Puebla, Pue.
Ruiz-Argüelles
A
A
Alemán-Hoey
D D
DD
Arizpe Bravo
D
D
Martin-López
A
A
Ocejo Rodríguez
A
A
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001215:Asparaginase / Q000008:administration & dosage; D016913:Blood Component Transfusion; D001804:Blood Transfusion, Autologous; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000628:therapy*; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D016879:Salvage Therapy
D011994:Recombinant Proteins; D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D001215:Asparaginase; D000069585:Filgrastim